Thomas A. Dix
Corporate Officer/Principal bei Medical University of South Carolina
Profil
Thomas A.
Dix is a Director and Chief Scientific Officer of Argolyn Bioscience, Inc. He is an Associate Professor of Pharmaceutical Sciences in the College of Pharmacy at the Medical University of South Carolina.
Previously, he was an Assistant Professor in the Departments of Chemistry and Biological Chemistry at the University of California, Irvine.
Dr. Dix received a PhD in Chemistry from Wayne State University.
Aktive Positionen von Thomas A. Dix
| Unternehmen | Position | Beginn |
|---|---|---|
| Medical University of South Carolina | Corporate Officer/Principal | 27.05.2009 |
Ehemalige bekannte Positionen von Thomas A. Dix
| Unternehmen | Position | Ende |
|---|---|---|
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Gründer | 26.11.2009 |
| University of California, Irvine | Corporate Officer/Principal | - |
Ausbildung von Thomas A. Dix
| Wayne State University (Michigan) | Doctorate Degree |
| The Pennsylvania State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Health Technology |
